In vivo and in vitro studies of Danzhi Jiangtang capsules against diabetic cardiomyopathy via TLR4/MyD88/NF-κB signaling pathway

OBJECTIVES: Danzhi Jiangtang capsule (DJC) is widely used for preventing and treating diabetic cardiomyopathy (DCM). However, the underlying mechanisms of the anti-inflammatory and antiapoptotic activities are unclear. METHODS: In the in vivo diabetic cardiomyopathy rat model, cardiac function was m...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Hui, Zhou, Peng, Ni, Ying-qun, Wang, Shu-shu, Song, Rui, Shen, An-lu, Fang, Zhao-hui, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720806/
https://www.ncbi.nlm.nih.gov/pubmed/35002381
http://dx.doi.org/10.1016/j.jsps.2021.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720806/
https://www.ncbi.nlm.nih.gov/pubmed/35002381
http://dx.doi.org/10.1016/j.jsps.2021.11.004

Ejemplares similares